HDAC6 SUPPRESSES NLRP3 INFLAMMASOME-DRIVEN HCC IMMUNOSUPPRESSION AND METASTASIS THROUGH NLRP3 AND HMGB1 DEACETYLATION

被引：0
|
作者：
Li, Dongxiao
Ding, Xiangming
Xie, Meng
Li, Deyu
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1281
引用
收藏
页码：S1258 / S1258
页数：1
相关论文
共 50 条
  • [1] The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
    Chang, Panpan
    Li, Hao
    Hu, Hui
    Li, Yongqing
    Wang, Tianbing
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Wang, Hao-yu
    Lin, Xi
    Huang, Guan-gen
    Zhou, Rong
    Lei, Shu-yue
    Ren, Jing
    Zhang, Kai-rong
    Feng, Chun-lan
    Wu, Yan-wei
    Tang, Wei
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (08) : 1687 - 1700
  • [3] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Hao-yu Wang
    Xi Lin
    Guan-gen Huang
    Rong Zhou
    Shu-yue Lei
    Jing Ren
    Kai-rong Zhang
    Chun-lan Feng
    Yan-wei Wu
    Wei Tang
    Acta Pharmacologica Sinica, 2023, 44 : 1687 - 1700
  • [4] Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release
    Bockstiegel, Judith
    Wurnig, Silas L.
    Engelhardt, Jonas
    Enns, Jana
    Hansen, Finn K.
    Weindl, Guenther
    BIOCHEMICAL PHARMACOLOGY, 2023, 215
  • [5] PKR IS REQUIRED FOR NLRP3 INFLAMMASOME ACTIVATION AND HMGB1 RELEASE
    Lu, B.
    Nakamura, T.
    Inouye, K.
    Valdes-Ferrer, S. I.
    Olofsson, P. S.
    Li, J.
    Wang, H.
    Andersson, U.
    Yang, H.
    Chavan, S. S.
    Hotamisligi, G. S.
    Tracey, K.
    SHOCK, 2012, 37 : 29 - 29
  • [6] PKR is required for NLRP3 inflammasome activation and HMGB1 release
    Lu, Ben
    Nakamura, Takahisa
    Inouye, Karen
    Valdes-Ferrer, Sergio
    Olofsson, Peder
    Li, Jianhua
    Wang, Haichao
    Erlandsson-Harris, Helena
    Kalb, Thomas
    Andersson, Ulf
    Yang, Huan
    Chavan, Sangeeta
    Hotamisligil, Goekhan
    Tracey, Kevin
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [7] HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy
    Kim, Jun-Sik
    Jun, Jae Hyun
    Lee, Jeongmi
    Park, Sunyoung
    Kim, Eunae
    Hwang, Su Jung
    Moon, Heesu
    Baek, Seung Hyun
    Kim, Hark Kyun
    Park, Jinsu
    Cho, Yoonsuk
    Han, Jihoon
    Kim, Chanhee
    Kim, Jongho
    Yang, Hyun-Mo
    Lee, Changsik
    Chung, Yeonseok
    Lee, Hyo-Jong
    Jo, Dong-Gyu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 164
  • [8] Tyrosine Phosphorylation of NLRP3 by Lyn Suppresses NLRP3 Inflammasome Activation
    Lin, Guoxin
    Tang, Juan
    Guo, Hui
    Xiao, Yun
    Gupta, Neetu
    Tang, Na
    Zhang, Jian
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [9] Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
    Huang, Y.
    Rong, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1892 - 1892
  • [10] Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
    Huang, Yi
    Jiang, Hua
    Chen, Yun
    Wang, Xiaqiong
    Yang, Yanqing
    Tao, Jinhui
    Deng, Xianming
    Liang, Gaolin
    Zhang, Huafeng
    Jiang, Wei
    Zhou, Rongbin
    EMBO MOLECULAR MEDICINE, 2018, 10 (04)
12345